Cargando…

Predictive and diagnostic biomarkers for gestational diabetes and its associated metabolic and cardiovascular diseases

Gestational diabetes mellitus (GDM) is defined as the presence of high blood glucose levels with the onset, or detected for the first time during pregnancy, as a result of increased insulin resistance. GDM may be induced by dysregulation of pancreatic β-cell function and/or by alteration of secreted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lorenzo-Almorós, A., Hang, T., Peiró, C., Soriano-Guillén, L., Egido, J., Tuñón, J., Lorenzo, Ó.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820966/ https://www.ncbi.nlm.nih.gov/pubmed/31666083 http://dx.doi.org/10.1186/s12933-019-0935-9

Ejemplares similares

Diagnostic approaches for diabetic cardiomyopathy
por: Lorenzo-Almorós, A., et al.
Publicado: (2017)

Cardiovascular Damage in COVID-19: Therapeutic Approaches Targeting the Renin-Angiotensin-Aldosterone System
por: Lumpuy-Castillo, Jairo, et al.
Publicado: (2020)

Targeting metabolic disturbance in the diabetic heart
por: Fuentes-Antrás, Jesús, et al.
Publicado: (2015)

Galectin-3 is Associated with Cardiovascular Events in Post-Acute Coronary Syndrome Patients with Type-2 Diabetes
por: Lorenzo-Almorós, Ana, et al.
Publicado: (2020)

Alteration of Energy Substrates and ROS Production in Diabetic Cardiomyopathy
por: Lorenzo, O., et al.
Publicado: (2013)

Potential Role of Nuclear Factor κB in Diabetic Cardiomyopathy
por: Lorenzo, O., et al.
Publicado: (2011)

Activation of Toll-Like Receptors and Inflammasome Complexes in the Diabetic Cardiomyopathy-Associated Inflammation
por: Fuentes-Antrás, J., et al.
Publicado: (2014)

Updating Experimental Models of Diabetic Cardiomyopathy
por: Fuentes-Antrás, J., et al.
Publicado: (2015)

Atrial Fibrillation and Diabetes Mellitus: Dangerous Liaisons or Innocent Bystanders?
por: Lorenzo-Almorós, Ana, et al.
Publicado: (2023)

Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes
por: González, N., et al.
Publicado: (2017)

Sitagliptin Reduces Cardiac Apoptosis, Hypertrophy and Fibrosis Primarily by Insulin-Dependent Mechanisms in Experimental type-II Diabetes. Potential Roles of GLP-1 Isoforms
por: Picatoste, Belén, et al.
Publicado: (2013)

Correction: Sitagliptin Reduces Cardiac Apoptosis, Hypertrophy and Fibrosis Primarily by Insulin-Dependent Mechanisms in Experimental type-II Diabetes. Potential Roles of GLP-1 Isoforms
por: Picatoste, Belén, et al.
Publicado: (2013)

The potential role of biomarkers in predicting gestational diabetes
por: Brink, Huguette S, et al.
Publicado: (2016)

IL-1β Inhibition in Cardiovascular Complications Associated to Diabetes Mellitus
por: Peiró, Concepción, et al.
Publicado: (2017)

MCP-1 Predicts Recurrent Cardiovascular Events in Patients with Persistent Inflammation
por: Blanco-Colio, Luis M., et al.
Publicado: (2021)

Maternal circulating metabolic biomarkers and their prediction performance for gestational diabetes mellitus related macrosomia
por: Yuan, Yingdi, et al.
Publicado: (2023)

NT-proBNP Levels Influence the Prognostic Value of Mineral Metabolism Biomarkers in Coronary Artery Disease
por: Martínez-Milla, Juan, et al.
Publicado: (2022)

Metabolic biomarkers for predicting cardiovascular disease
por: Montgomery, Jana E, et al.
Publicado: (2013)

Inflammatory and Other Biomarkers: Role in Pathophysiology and Prediction of Gestational Diabetes Mellitus
por: Abell, Sally K., et al.
Publicado: (2015)

Sitagliptin improved glucose assimilation in detriment of fatty-acid utilization in experimental type-II diabetes: role of GLP-1 isoforms in Glut4 receptor trafficking
por: Ramírez, E., et al.
Publicado: (2018)

Predictive Gestational Diabetes Biomarkers With Sustained Alterations Throughout Pregnancy
por: Heath, Hannah, et al.
Publicado: (2022)

Discovery of metabolic biomarkers for gestational diabetes mellitus in a Chinese population
por: Lu, Wenqian, et al.
Publicado: (2021)

Common pathways of hypercholesterolemia and hypertension leading to atherothrombosis: the need for a global approach in the management of cardiovascular risk factors
por: Tuñón, José, et al.
Publicado: (2007)

DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
por: Valencia, Inés, et al.
Publicado: (2020)

Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes
por: Ramírez, Elisa, et al.
Publicado: (2013)

The diagnostic model for early detection of gestational diabetes mellitus and gestational diabetic nephropathy
por: Chong, Huimin, et al.
Publicado: (2022)

Diagnostic Biomarkers for Gestational Diabetes Mellitus Using Spectroscopy Techniques: A Systematic Review
por: Khan, Rabia Sannam, et al.
Publicado: (2023)

Gestational Diabetes: Physical Activity Before Pregnancy and Its Influence on the Cardiovascular System
por: Sitzberger, Christina, et al.
Publicado: (2020)

Thromboelastography (TEG) in normal pregnancy and its diagnostic efficacy in patients with gestational hypertension, gestational diabetes mellitus, or preeclampsia
por: Xie, Xin, et al.
Publicado: (2020)

Docosahexaenoic acid supplementation in gestational diabetes mellitus and neonatal metabolic health biomarkers
por: Xu, Ya-Jie, et al.
Publicado: (2023)

An early prediction model for gestational diabetes mellitus based on metabolomic biomarkers
por: Razo-Azamar, Melissa, et al.
Publicado: (2023)

miR-132 serves as a diagnostic biomarker in gestational diabetes mellitus and its regulatory effect on trophoblast cell viability
por: Zhou, Xuegui, et al.
Publicado: (2019)

Association of Concomitant Gestational Hypertensive Disorders and Gestational Diabetes With Cardiovascular Disease
por: Echouffo Tcheugui, Justin B., et al.
Publicado: (2022)

Molecular Biomarkers for Gestational Diabetes Mellitus
por: Dias, Stephanie, et al.
Publicado: (2018)

Diagnostic accuracy of first and early second trimester multiple biomarkers for prediction of gestational diabetes mellitus: a multivariate longitudinal approach
por: Shaarbaf Eidgahi, Elham, et al.
Publicado: (2022)

Potential Role of the mTORC1-PGC1α-PPARα Axis under Type-II Diabetes and Hypertension in the Human Heart
por: Hang, Tianyu, et al.
Publicado: (2023)

A Predictive Metabolic Signature for the Transition From Gestational Diabetes Mellitus to Type 2 Diabetes
por: Allalou, Amina, et al.
Publicado: (2016)

The Emerging Role of Biomarkers in the Diagnosis of Gestational Diabetes Mellitus
por: Rodrigo, Natassia, et al.
Publicado: (2018)

Molecular biomarkers for gestational diabetes mellitus and postpartum diabetes
por: Lu, Wenqian, et al.
Publicado: (2022)

Emerging Protein Biomarkers for the Diagnosis or Prediction of Gestational Diabetes—A Scoping Review
por: Bogdanet, Delia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_epv4cl5g027292gh4hhu4nscpr